ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need
34 employees · est. 1981
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
68 employees · est. 2019 · Boston, United States
ImmunoGen is the older company (1981 vs 2019); Pyxis Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | ImmunoGen | Pyxis Oncology |
|---|---|---|
| Founded | ||
| Founded | 1981 older | 2019 |
| Headquarters | ||
| Headquarters | Not tracked yet | Boston, United States |
| Employees | ||
| Employees | 34 | 68 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Acquired | Unknown |
| Total Funding | ||
| Total Funding | $681.30M | $392.00M |
| Funding Rounds | ||
| Funding Rounds | 11 | 4 |
| Services | ||
| Services | Drug Development, Clinical Trials Management, Cancer Research and Treatment Solutions, Healthcare Professional Support | development of antibody-drug conjugates, immunotherapy research, clinical program management, oncology-focused drug development |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Healthcare Providers, Research Institutions | patients with difficult-to-treat cancers, healthcare professionals, oncologists, medical researchers |
| Taxonomy | ||
| Taxonomy | Antibody-drug Conjugates, Cancer Treatment, Oncology, Immunology, Neuroscience, Therapeutics Development, Targeted Antibody Payload (TAP) Technology, Metastatic Breast Cancer, Hematological Malignancies, Solid Tumors, Collaboration Agreements, Licensing Partnerships | Antibody-Drug Conjugates, Immunotherapy, Cancer Treatment, Biologics, Tumor Targeting, Immune Suppression Overcoming, Tumor Antigen-Specific TILs, Tumor-Infiltrating Lymphocytes, Cold Tumors, Hot Tumors, Tumor Cell Signaling, Antibody-Based Immunotherapies, Oncology Innovation, Therapeutic Development |
| Website | ||
| Website | immunogen.com | pyxisoncology.com |
About ImmunoGen
ImmunoGen, Inc. is a biotechnology innovator, harnessing the potential of antibody-drug conjugates (ADCs) to revolutionize cancer treatment. With a focus on oncology, the company combines the precision of antibodies with the effectiveness of cytotoxic drugs, aiming to target cancer cells while spari...
About Pyxis Oncology
Pyxis Oncology, founded in 2019, is a biotech innovator based in the United States, focused on transformative cancer therapies. With a mission expressed through their slogan, "Charting a course to therapeutics for difficult-to-treat cancer," Pyxis aims to change the landscape of cancer treatment. T...
We will tell you when either one moves
BounceWatch watches ImmunoGen and Pyxis Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ImmunoGen and Pyxis Oncology — by email.
Frequently Asked Questions
Compare ImmunoGen with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ImmunoGen on 10 Jun 2026, and Pyxis Oncology on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.